Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease

BACKGROUND AND AIM: Thrombocytopenia is common in people with chronic liver disease, who frequently undergo invasive procedures. To minimize the risk of bleeding, prophylactic platelet transfusions have traditionally been used but carry many risks. The aim of this study was to evaluate the cost-effe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clinicoecon Outcomes Res
Hlavní autoři: Mladsi, Deirdre, Barnett, Christine, Aggarwal, Kavita, Vredenburg, Michael, Dieterich, Douglas, Kim, Ray
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7500829/
https://ncbi.nlm.nih.gov/pubmed/32982341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S262772
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky